The study found that while 47% of US consumers are familiar with CBD, 38% are entirely unfamiliar with the ingredient, and many of those who do know about CBD are highly likely to be confused or unaware of the science or legality behind it. Of those consumers who are...
The US Food and Drug Administration (FDA) has issued warning letters, in collaboration with the Federal Trade Commission (FTC), to three companies—Advanced Spine and Pain (doing business as Relievus), Nutra Pure, and PotNetwork Holdings—in response to their making...
